ac220
Showing 1 - 7 of 7
Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood Trial in United States (AC220, Cytarabine,
Completed
- Lymphoblastic Leukemia, Acute, Childhood
- Myelogenous Leukemia, Acute, Childhood
- AC220
- +3 more
-
Los Angeles, California
- +10 more
Mar 24, 2022
Leukemia, Myeloid, Acute Trial in United States (AC220)
Completed
- Leukemia, Myeloid, Acute
- AC220
-
Duarte, California
- +4 more
Feb 8, 2019
Leukemia, Myeloid, Acute Trial in United States (AC220, daunorubicin, cytarabine)
Completed
- Leukemia, Myeloid, Acute
- AC220
- +2 more
-
Jacksonville, Florida
- +4 more
Feb 8, 2019
Relapsed AML, Refractory AML Trial in Tokyo (AC220)
Completed
- Relapsed AML
- Refractory AML
- AC220
-
Tokyo, Japan(unnamed)
Feb 8, 2019
Acute Myeloid Leukaemia, High Risk Myelodysplastic Syndrome Trial in United Kingdom (Plerixafor, AC220, Ganetespib)
Completed
- Acute Myeloid Leukaemia
- High Risk Myelodysplastic Syndrome
- Plerixafor
- +2 more
-
Aberdeen, United Kingdom
- +12 more
Jun 10, 2014